艾德生物: 关于披露简式权益变动报告书的提示性公告

Core Viewpoint - The equity change by Ningbo Yixiang Investment Partnership will not affect the company's governance structure or ongoing operations, nor will it lead to changes in the controlling shareholder or actual controller [1]. Summary of Equity Changes - Since the company's initial public offering, the equity changes of Yixiang Investment are as follows: - After a cash dividend of 2.4 RMB per 10 shares and a capital reserve increase of 8 shares per 10 shares, the total share capital increased to 144 million shares, with Yixiang Investment holding 13,667,400 shares, representing 9.491250% of the total [1]. - Following various stock repurchases and capital increases, Yixiang Investment's shareholding has been diluted to 9.286117% and subsequently to 9.237133% as the total share capital fluctuated [2][3]. - After the 2019 dividend distribution, Yixiang Investment's shares increased to 20,501,100, maintaining a 9.237133% stake despite the total share capital rising to 221,942,250 shares [2]. - The shareholding was further diluted to 6.688082% after a series of share reductions and repurchases, with Yixiang Investment holding 14,834,700 shares [3]. - By the end of 2022, after a significant reduction in shares, Yixiang Investment's holding decreased to 20,026,900 shares, representing 5.074915% of the total share capital [5]. - As of November 2023, following additional share repurchases, Yixiang Investment's stake was further diluted to 5.095100% with 20,026,900 shares held [6][7]. Shareholding Situation Before and After Changes - Before the recent equity changes, Yixiang Investment held 7,593,000 shares, representing 9.491250% of the total share capital. After the changes, the holding decreased to 19,576,800 shares, which is 4.999998% of the total [7].